Related Experiment Video
Updated: Jun 2, 2026
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic
Ramon Edmundo D Bautista1, Walter Gonzales, Deepali Jain
1Department of Neurology, University of Florida Health Sciences Center/Jacksonville, 580 West Eighth Street, Jacksonville, FL 32209, USA. ramon.bautista@jax.ufl.edu
Objective:
To determine those factors associated with increased seizures and side effects after switching from brand name to generic antiepileptic drugs (AEDs).
Methods:
We surveyed adult epilepsy patients and obtained demographic, clinical, and psychosocial data. We inquired whether they switched from brand name to generic AEDs, and whether they experienced poorer seizure control and increased side effects. Using univariate analysis, we determined those variables significantly associated with increased seizures and side effects. We applied binary logistic regression to determine those independently associated with these target variables.
Results:
One hundred and twenty-one subjects completed the questionnaire. Seventy-one switched to generic AEDs. Of these, 18 subjects (25.7%) reported increased seizure frequency. This was associated with high seizure count (p=0.03) and scores on the Beliefs About Medicines-General (BMQ-G) questionnaire (p=0.04). On multivariate analysis, these variables were not independently significant. Fourteen subjects (20.6%) reported increased side effects. This was associated with being African-American (p=0.04), and high scores on the BMQ-G (p=0.01). On multivariate analysis, BMQ-G scores were independently associated with increased adverse effects.
Interpretation:
High baseline seizure count is associated with increased seizure frequency while high BMQ-G scores are associated with increased seizure frequency and adverse effects when patients switch from brand name to generic AEDs.
More Related Videos
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...